SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
(Rule 14d-101)
Solicitation/Recommendation Statement
Under Section 14(d)(4) of the Securities Exchange Act of 1934
ZymoGenetics, Inc.
(Name of Subject Company)
ZymoGenetics, Inc.
(Name of Person Filing Statement)
Common Stock, no par value
(Title of Class of Securities)
98985T109
(CUSIP Number of Class of Securities)
James A. Johnson
Executive Vice President, Chief Financial Officer, Secretary and Treasurer
1201 Eastlake Avenue East,
Seattle, Washington 98102
(206) 442-6600
(Name, address and telephone number of person authorized to receive
notices and communications on behalf of the persons filing statement)
With copies to:
Peter F. Kerman
Joshua M. Dubofsky
Latham & Watkins LLP
140 Scott Drive
Menlo Park, CA 94025
(650) 328-4600
| x | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
The information set forth under Items 1.01, 5.02 and 9.01 of the Current Report on Form 8-K filed by ZymoGenetics, Inc. on September 8, 2010 (including all exhibits attached thereto) are incorporated herein by reference.